Brenmiller Energy secures EUR 25M in funding for SolWinHy Project
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
Atos Group publishes estimated 2025 half-year liquidity position reflecting limited cash consumption in the half
By GlobeNewswire Published on July 20, 2025, 23:00 IST Press Release Atos Group publishes estimated 2025 half-year liquidity position reflecting limited cash consumption in the half Paris, July 20th, 2025 – Atos Group (Euronext Paris: ATO) today publishes an estimated 2025 half-year liquidity position. This publication is part of the regular reporting requirements defined and agreed with the Group's financial creditors. Net change in cash1 in the first half of 2025 is estimated at c. €-96 million (vs €-686 million in the first half of 2024), without any usage of account receivable factoring or specific optimization on trade payables. This is before the estimated impact of exchange rate fluctuation of €-103 million (mainly driven by the EUR/USD evolution during the half) and excluding the €-175 million variance in payments received in advance of invoice payment due date. As at June 30, 2025, Atos Group liquidity2 is estimated at €1,804 million, compared to €2,179 million as of December 31, 2024 and more than €1.1 billion above the minimum €650 million level required by credit documentation. It was comprised of: In € million June 30, 2025 (estimated) Dec 31, 2024 (actuals) Variation Cash & cash equivalent 1,364 1,739 (374) Of which payments received in advance of invoice payment due date 143 319 (175) Undrawn revolving credit facility 440 440 – Total liquidity2 1,804 2,179 (374) The liquidity report is available on the company website ( Disclaimer This document contains forward-looking statements that involve risks and uncertainties, including references, concerning the Group's expected growth and profitability in the future which may significantly impact the expected performance indicated in the forward-looking statements. These risks and uncertainties are linked to factors out of the control of the Company and not precisely estimated, such as market conditions or competitors' behaviors. Any forward-looking statements made in this document are statements about Atos's beliefs and expectations and should be evaluated as such. Forward-looking statements include statements that may relate to Atos's plans, objectives, strategies, goals, future events, future revenues or synergies, or performance, and other information that is not historical information. Actual events or results may differ from those described in this document due to a number of risks and uncertainties that are described within the 2024 Universal Registration Document filed with the Autorité des Marchés Financiers (AMF) on April 10, 2025 under the registration number D.25-0238. Atos does not undertake, and specifically disclaims, any obligation or responsibility to update or amend any of the information above except as otherwise required by law. This document does not contain or constitute an offer of Atos's shares for sale or an invitation or inducement to invest in Atos's shares in France, the United States of America or any other jurisdiction. This document includes information on specific transactions that shall be considered as projects only. In particular, any decision relating to the information or projects mentioned in this document and their terms and conditions will only be made after the ongoing in-depth analysis considering tax, legal, operational, finance, HR and all other relevant aspects have been completed and will be subject to general market conditions and other customary conditions, including governance bodies and shareholders' approval as well as appropriate processes with the relevant employee representative bodies in accordance with applicable laws. About Atos Group Atos Group is a global leader in digital transformation with c. 72,000 employees and annual revenue of c. €10 billion, operating in 68 countries under two brands — Atos for services and Eviden for products. European number one in cybersecurity, cloud and high-performance computing, Atos Group is committed to a secure and decarbonized future and provides tailored AI-powered, end-to-end solutions for all industries. Atos is a SE (Societas Europaea) and listed on Euronext Paris. The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space. Contact Investor relations: [email protected] Individual shareholders: +33 8 05 65 00 75 Media relations: [email protected] 1 Net change in cash is defined as the variance in cash and cash-equivalent – before impact of exchange rate fluctuation – excluding (i) the variance of the drawn portion of the RCF and (ii) the variance in working capital optimization actions (which include cash in advance received from customers, account receivable factoring and specific optimization of trade payables) 2 Liquidity is defined as the sum of (i) the consolidated cash and cash-equivalent position of the Group and (ii) the amounts available under any undrawn committed facilities (including committed overdrafts). Consolidated cash and cash-equivalent includes trapped cash and unpooled cash and excludes cash held in escrow accounts in order to provide cash collateral. Attachment 20250720 – PR – Atos Group – June 2025 liquidity Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
2 days ago
- Yahoo
Orion Oyj (ORINY) (Q2 2025) Earnings Call Highlights: Strong Growth in Net Sales and Operating ...
Net Sales Growth: 27% increase to EUR416.5 million in Q2 2025. Operating Profit Growth: 59% increase with an operating profit margin of 25%. Operating Cash Flow Per Share: Increased almost 200% to EUR0.57 per share. First Half Net Sales: More than 20% growth to EUR771 million. First Half Operating Profit: Almost 50% growth to EUR182.5 million. First Half Operating Cash Flow Per Share: EUR1.12 per share. Innovative Medicines Growth: Around 80% growth both quarterly and half-yearly. Branded Products Growth: More than 10% growth in Q2 and first half of the year. Generics Growth: 6.7% growth in Q2 and almost 4% in the first half of the year. Animal Health Growth: Almost 23% growth. Updated Outlook for 2025: Net sales expected between EUR1.630 billion and EUR1.730 billion; operating profit between EUR400 million and EUR500 million. Warning! GuruFocus has detected 5 Warning Sign with ORINY. Release Date: July 18, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Orion Oyj (ORINY) reported a 27% increase in net sales, reaching EUR416.5 million for Q2 2025. Operating profit grew by 59%, with an operating profit margin of 25%. The company received FDA approval and CHMP recommendation for darolutamide in combination with ADT for metastatic hormone-sensitive prostate cancer. Orion Oyj (ORINY) expanded its research pipeline, including a new agreement with Glykos for antibody drug conjugates and a partnership with Shilpa for recombinant albumin. The Easyhaler portfolio is projected to exceed EUR300 million in annual sales, indicating strong growth potential. Negative Points Fermion division experienced slightly lower sales due to capacity constraints. Simdax and Trexan prices are decreasing due to generic competition, impacting revenue. There is uncertainty in the second half of the year regarding Nubeqa sales and R&D expenses, leading to a wide guidance range. Potential US pharma tariffs could impact sales, though the exact effect remains uncertain. R&D expenses are expected to increase in the second half of the year, potentially affecting profitability. Q & A Highlights Q: Why is Orion maintaining a wide guidance range despite a strong first half of the year? A: Rene Lindell, CFO, explained that uncertainties remain, particularly with Nubeqa's sales and royalty percentages, which peak in Q4. Additionally, R&D expenses can vary significantly based on project timing, affecting the financial outlook. Q: Should we expect a significant increase in R&D costs in the second half of the year? A: Rene Lindell noted that while R&D expenses were lower than expected in the first half, they are anticipated to rise slightly in the second half as projects progress, though not significantly. Q: What are the CEO's current priorities and main challenges for Orion? A: Liisa Hurme, CEO, emphasized filling the clinical pipeline and ensuring the success of Nubeqa with Bayer as top priorities. She also highlighted the importance of maintaining strong performance across all business divisions. Q: How could potential US pharma tariffs impact Orion's business? A: Liisa Hurme stated that while tariffs are a concern, they are not expected to materially impact this year's results. Orion is preparing for various scenarios, but no immediate changes are planned, such as establishing US production capacity. Q: What is the status of Orion's R&D pipeline, and what developments are expected? A: Liisa Hurme mentioned that Phase I for ODM-202 is expected to conclude by the end of the year, potentially leading to Phase II in 2026. Additionally, new biologics are anticipated to enter the clinical pipeline within the next 12 to 24 months. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
3 days ago
- Yahoo
EQT AB (EQBBF) H1 2025 Earnings Call Highlights: Record Exit Volumes and Strong Fundraising ...
Exit Volumes: More than tripled compared to the first half of last year. Realizations: Exceeded investments with a weighted average return of 2.3x over the last 12 months. Capital Deployment: EUR7 billion of capital invested during the first half. Proceeds Generated: Approximately EUR20 billion for investors over the last 12 months. Fundraising: Gross inflows of EUR18 billion, with Infrastructure VI closing at EUR21.5 billion. Management Fees Growth: Increased by 10% year-over-year. EBITDA Margin: Increased to 60%, up from 56% in the first half of 2024. Carried Interest and Investment Income: Increased to EUR191 million, up from EUR41 million in H1 of '24. Dry Powder: Approximately EUR50 billion available. Exit Announcements: Approximately EUR13 billion in exits announced in the first half of the year. Target Returns: Realized return of about 2.4x in Private Capital (Trades, Portfolio), 2.1x in Infrastructure, and 2.9x in Asia. Warning! GuruFocus has detected 5 Warning Signs with EQBBF. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points EQT AB (EQBBF) achieved a significant increase in exit volumes, more than tripling compared to the first half of the previous year, with realizations exceeding investments. The company successfully closed Infra IV at hard cap and launched EQT XI, demonstrating strong fundraising capabilities. EQT Nexus expanded its availability to over 20 countries, and two new evergreen vehicles were launched, enhancing the company's private wealth offerings. EQT AB (EQBBF) maintained a strong global presence and geographical diversification, which positions it well to deliver alpha for clients in a volatile market. The company reported a robust pipeline for the second half of the year, with significant opportunities in Asia, particularly in India and Japan. Negative Points The fundraising environment remains challenging, with a slower deal-making environment in certain regions. EQT AB (EQBBF) faces potential risks from currency fluctuations, as the depreciation of the dollar against the euro negatively impacted fund valuations. The company anticipates a longer time to achieve target MOIC returns for EQT IX and Infrastructure V compared to prior vintages. There is uncertainty regarding the exact timing of when Infra IV will enter carry mode, with expectations set for 2027 unless market conditions improve significantly. The company is undergoing organizational changes to streamline operations, which may introduce short-term disruptions as it integrates functions and reduces complexity. Q & A Highlights Q: How should we view the EUR23 billion target for EQT XI compared to EQT X? Is it due to tough fundraising markets? A: The EUR23 billion target for EQT XI is based on the previous fundraising amount for EQT X, which was EUR20 billion, and ended up raising EUR22 billion. We see good momentum in the fundraising for EQT XI, and the final hard cap is yet to be determined. - Per Franzen, CEO Q: Could you explain the expected EUR100 billion fundraising cycle and the role of evergreen funds? A: The EUR100 billion fundraising cycle includes a significant portion from our flagship funds. Evergreen funds are expected to contribute around 10% of the capital, primarily through co-investments and US evergreen strategies. These funds invest alongside our main funds, not directly into them. - Gustav Segerberg, Head of Business Development Q: What are the strategic changes you have implemented since becoming CEO, and what more is planned? A: We've reorganized parts of the firm, established a new leadership team, and plan further actions to maintain agility and capitalize on growth opportunities. This includes slowing net headcount growth and optimizing costs. - Per Franzen, CEO and Kim Henriksson, CFO Q: How does the potential inclusion of 401(k) plans in private markets impact EQT's strategy? A: The 401(k) market presents a significant growth opportunity for our evergreen strategies. While initial focus may be on more liquid strategies like credit, we expect private equity, infrastructure, and real estate to become relevant over time. - Gustav Segerberg, Head of Business Development and Per Franzen, CEO Q: Can you provide more details on the EUR1 billion carry expected from existing funds? A: The EUR1 billion carry from funds currently in carry mode is expected to be realized over more than two years, depending on market conditions and exit readiness. - Kim Henriksson, CFO Q: What is EQT's approach to potential new strategies, such as private credit? A: We are exploring opportunities to fill gaps in our platform, including secondary solutions in private markets. This aligns with client interests and could strengthen our relationships with investors. - Per Franzen, CEO Q: How do you view the current exit environment, and what are your expectations for H2? A: We have a strong exit pipeline and are optimistic about achieving our original exit agenda for the year, provided market conditions remain stable. - Per Franzen, CEO Q: How do you plan to address the FX impact on EBITDA margins? A: We monitor FX impacts closely but do not hedge. Approximately 45% of our revenue and one-third of our costs are USD-based. We adapt as necessary to manage these impacts. - Kim Henriksson, CFO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
